ClinicalTrials.gg
CompletedNCT02053428Updated Nov 17, 2014

Comparison of Percutaneous Image-guided Gastrostomies

An interventional study of percutaneous image-guided gastrostomy in Cancer of Head and Neck, sponsored by University Health Network, Toronto. Completed at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2014-11-17.

Sponsored by University Health Network, Toronto · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Percutaneous image-guided gastrostomy (PIG) is an increasingly popular technique of creating gastroenteric access through the anterior abdominal wall for nutrition and/ or compression. Large-bore mushroom-retained catheters via the pull technique and small-bore cope loop catheters via the push technique are both used at Interventional Radiology for PIG at our institution. To date, there is no guideline for PIG and no direct comparison of two PIG techniques. The proposed pilot study is to compare the two different types of PIG techniques in head and neck cancer patients who require prophylactic enteral feeding by PIG. The purpose of the study is to assess the feasibility of a large randomized clinical trial to compare these two PIG techniques.

02

Conditions studied

  • Cancer of Head and Neck

Keywords

  • Head and neck cancer
  • Percutaneous image-guided gastrostomy
  • Pain
  • Quality of life
  • Complication
03

In context

Head and Neck Neoplasms

2,403 studies on the registry are indexed under Head and Neck Neoplasms; 559 are open to participants now.

This study's enrollment of 60 is above the median of 47 across 1,791 interventional studies indexed under Head and Neck Neoplasms.

Browse Head and Neck Neoplasms studies →

Lead sponsor

University Health Network, Toronto is the lead sponsor of 1,432 studies on the registry; 292 are open to participants now.

Of its 17 completed or terminated interventional studies of FDA-regulated products, 3 (18%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Male or female ≥18 years;
  2. Life expectancy > 6 months;
  3. Diagnosed with head and neck cancer; and
  4. Scheduled to have prophylactic enteral feeding by percutaneous image-guided gastrostomy performed in the interventional radiology suite.

Exclusion criteria

Exclusion Criteria:

  1. Pregnancy; or
  2. Established pharyngeal obstruction and/or presence of an enteral feeding device.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (actual)

Study arms

  • Active comparator
    Gastrostomy - pull technique

    Percutaneous image-guided gastrostomy using large-bore mushroom-retained catheters via the pull technique

    Procedure: percutaneous image-guided gastrostomy

  • Active comparator
    Gastrostomy - push technique

    Percutaneous image-guided gastrostomy using small-bore cope loop catheters via the push technique

    Procedure: percutaneous image-guided gastrostomy

Interventions

  • Procedurepercutaneous image-guided gastrostomy
06

What researchers measure

Primary outcomes

  1. Pain experience

    The primary objective of this study is to compare the level of pain experienced, measured by the dose of sedation used during the procedure, and numerical rating scale (NRS)

    Time frame: pre, 1-hour, 2-hour, 3-hour, 1-day, 2-day, 3-day and weekly for up to six weeks post procedure

Secondary outcomes

  1. Technical success

    successful placement of percutaneous image-guided gastrostomy

    Time frame: Day 0 post procedure

  2. Catheter malfunction rate

    tube clogging, dislodgement and/or leakage

    Time frame: Up to six months post procedure

  3. Tube site complications

    Skin infection on tube exit

    Time frame: Up to six months post procedure

  4. Quality of life

    Quality of life for patients undergoing different types of PIG procedures.

    Time frame: Up to six weeks post procedure

07

Study locations

1 site
  • University Health Network
    Toronto, Ontario M5G 2N2, Canada
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jun 2013, a primary completion of Apr 2014 and a completion of Oct 2014. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 21, 2014
First posted
Feb 3, 2014
Start
Jun 2013
Primary completionActual
Apr 2014
CompletionActual
Oct 2014
Last update
Nov 17, 2014
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 17, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02053428
Responsible party
Sponsor
First posted
Feb 3, 2014
Start date
Jun 2013
Primary completion
Apr 2014
Completion
Oct 2014
Last update
Nov 17, 2014

Study contacts

Kong Teng Tan, MB BCH BAO
principal investigator · University Health Network, Toronto

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion